Mingjun Sun

Dr. Mingjun Sun


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2020 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
MLMengyuan Liu
Mengyuan Liu
RWRuoyu Wang
Ruoyu Wang
XSXuren Sun
Xuren Sun
YLYuting Liu
Yuting Liu
ZWZhi Wang
Zhi Wang
MSMingjun Sun
Mingjun Sun
Although circulating tumor cells (CTCs) have shown promise as potential biomarkers for diagnostic and prognostic assessment in gastric cancer (GC), determining the predictive and prognostic value of programmed death‐ligand 1 (PD‐L1)‐positive CTCs in patients with GC is a challenge. Here, we identified that the expression of total vimentin (VIM) protein was positively correlated with PD‐L1 and inhibited CD8+ T‐cell activation in patients with GC according to bioinformatics analysis. Notably, coexpression of PD‐L1 and cell‐surface VIM (CSV) was detected by immunofluorescence and immunohistochemistry assay in locally advanced GC tumor specimens and metastatic lymph nodes. Likewise, CSV expression level was significantly decreased after transiently knocking down PD‐L1 in GC cell lines. Based on our established CTC detection platform, CTCs were isolated from peripheral blood samples collected from 70 patients (38 resectable and 32 unresectable) with GC using magnetic positive selection and a CSV‐specific monoclonal antibody, 84‐1. CSV+PD‐L1+CTCs were observed in 50 of 70 (71%) GC patient samples, ranging from 0 to 261 mL−1. A higher number of CSV+PD‐L1+CTCs were significantly associated with a short survival duration and poor therapeutic response. This study demonstrated that detection of PD‐L1+CTCs using a CSV‐enrichment method has promising value as a clinically relevant prognostic marker for GC.

1 March 2019 in Molecular Therapy-Oncolytics
Verified
Journal Article
Open access
JWJiani Wang
Jiani Wang
MCMichelle Cheng
Michelle Cheng
ILIvy K.M. Law
Ivy K.M. Law
COChristina Ortiz
Christina Ortiz
MSMingjun Sun
Mingjun Sun
Hon Wai KoonHon Wai Koon
Hon Wai Koon
The antimicrobial peptide cathelicidin inhibits development of colitis-associated colon cancer. However, the role of cathelicidin in colon cancer metastasis remains unknown. We hypothesized that cathelicidin is effective in inhibiting colon cancer metastasis. Human colon cancer HT-29 cells were injected intravenously into nude mice. Control HA-tagged adeno-associated virus (HA-AAV) or cathelicidin-overexpressing AAV (CAMP-HA-AAV) were injected intravenously into nude mice on the same day. Four weeks later, the nude mice were assessed for lung and liver metastases. Human colon cancer SW620 cells were used to study the effect of cathelicidin on cell migration and cytoskeleton. Incubation of SW620 cells with cathelicidin dose-dependently reduced cell migration, disrupted cytoskeletal structure, and reduced βIII-tubulin (TUBB3) mRNA expression. The addition of the P2RX7 antagonist KN62, but not the FPRL1 antagonist WRW4, prevented the LL-37-mediated inhibition of cell migration and TUBB3 mRNA expression. The CAMP-HA-AAV-overexpressing group showed significantly reduced human CK20 protein (by 60%) and TUBB3 mRNA expression (by 40%) in the lungs and liver of the HT-29-loaded nude mice, compared to the HA-AAV control group. Intraperitoneal injection of KN62 reversed the CAMP-HA-AAV-mediated inhibition of human CK20 and TUBB3 expression in the lungs and liver of HT-29-loaded nude mice. In conclusion, cathelicidin inhibits colon cancer metastasis via a P2RX7-dependent pathway.

26 April 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
XSXuren Sun
Xuren Sun
ZSZhe Sun
Zhe Sun
ZZZhi Zhu
Zhi Zhu
CLChenyan Li
Chenyan Li
JZJunyan Zhang
Junyan Zhang
MSMingjun Sun
Mingjun Sun

28 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYouzhu Lu
Youzhu Lu
JJJingjing Jing
Jingjing Jing
LSLiping Sun
Liping Sun
YGYuehua Gong
Yuehua Gong
MCMoye Chen
Moye Chen
YYYuan Yuan
Yuan Yuan
Claudins play an important role in regulating the permeability of epithelial and endothelial cells and in the maintenance of cell polarity. We aimed to investigate expression of claudin-11, -23 in different gastric tissues and its relationship with clinicopathologic parameters and prognosis of gastric cancer. We compared their expression levels in the paired cancerous tissues versus those in the adjacent noncancerous tissues by real-time PCR, western blotting and immunohistochemistry. The results showed that the expression of claudin-11, -23 was greatly increased in paracancerous gastric tissue compared with cancerous tissue. We also compared their expression levels of tissues from gastric cancer, superficial gastritis, and atrophic gastritis by immunohistochemistry. The results indicated that the expression of claudin-11 and 23 was significantly higher in superficial gastritis than that in atrophic gastritis and gastric cancer. The expression of claudin-23 was significantly lower in atrophic gastritis than that in gastric cancer, but no obviously difference was observed for claudin-11. As for analysis of clinicopathologic parameters of gastric cancer, logistic multiple regression indicated that claudin-11 was significantly associated with sex, smoking, alcohol, H. pylori infection and Borrmann classification while claudin-23 was significantly associated with vessel cancer embolus. Cox multivariate survival analysis indicated that gastric cancer patients with negative claudin-23 expression had significantly longer overall survival. In conclusion, the expression of claudin-11, -23 was remarkably downregulated in gastric cancer. Abnormal expression of these proteins was significantly correlated with some clinicopathologic parameters. In particular, claudin-23 positive expression was associated with poor prognostic outcomes of gastric cancer patients and may therefore serve as an independent prognosticator of patient survival.

23 April 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
YZYining Zhang
Yining Zhang
ZYZhaojin Yu
Zhaojin Yu
QXQinghuan Xiao
Qinghuan Xiao
XSXuren Sun
Xuren Sun
ZZZhi Zhu
Zhi Zhu
MSMingjun Sun
Mingjun Sun

25 June 2011 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
WLWen Li
Wen Li
HXHong Xu
Hong Xu
ZWZi-Kai Wang
Zi-Kai Wang
ZFZhi-Ning Fan
Zhi-Ning Fan
SBShan-Duo Ba
Shan-Duo Ba
JXJian-Guo Xiao
Jian-Guo Xiao